[October 12, 2017]

Male Health Drug Development Pipeline Review, 2017 - Research and Markets

The "Male Health Drug Development Pipeline Review, 2017" report has been added to Research and Markets' offering.

The report, "Male Health Drug Development Pipeline Review, 2017" provides an overview of the male health pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Male Hypogonadism, Erectile Dysfunction and Benign Prostatic Hyperplasia and features dormant and discontinued projects.

Scope

• Which companies are the most active within the pipeline for male health therapeutics?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&am;D milestones and data publications to have happened in the field of male health?

1 Table of Contents

2 Introduction

3 Therapeutics Development

4 Therapeutics Assessment

5 Companies Involved in Therapeutics Development

6 Dormant Projects

7 Discontinued Products

8 Product Development Milestones

9 Appendix

Companies Mentioned

• Addex Therapeutics Ltd
• AndroScience Corp
• Can-Fite BioPharma Ltd
• Health Ever Bio-Tech Co Ltd
• Humanetics Corp
• IntelGenx Corp
• Ion Channel Innovations LLC
• iX Biopharma Ltd
• Jeil Pharmaceutical Co Ltd
• Lipocine Inc
• M et P Pharma AG
• MEI Pharma Inc
• Medlab Clinical Ltd
• Meiji Seika Pharma Co Ltd
• Merck & Co Inc
• Mereo Biopharma Group Plc
• Mezzion Pharma Co Ltd
• Mitsubishi (News - Alert) Tanabe Pharma Corp
• Monosol Rx LLC
• N4 Pharma Plc
• NAL Pharmaceuticals Ltd
• Suda Ltd
• Sun Pharma Advanced Research Company Ltd
• TesoRx Pharma LLC
• The Female Health Company
• Yungjin Pharm Co Ltd
• Yuyu Pharma Inc

For more information about this report visit https://www.researchandmarkets.com/research/hhp5rz/male_health_drug

View source version on businesswire.com: http://www.businesswire.com/news/home/20171012005838/en/

[ Back To TMCnet.com's Homepage ]